Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Partners with Clinical Research Organization to Provide Pharmacogenomic Services

NEW YORK, June 7 (GenomeWeb News) - Genaissance Pharmaceuticals will provide pharmacogenomic services through clinical contract research organization INC Research, the company said today.


INC Research, based in Raleigh, NC, focuses on clinical research in oncology, pediatrics, and the central nervous system. Genaissance will offer pharmacogenetic clinical development sevices to INC's clients.


This is Genaissance's first partnership with a clinical research organization, according to the company.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.